(Q45255045)

11 December 2017

title

Summary of worldwide clinical experience with H-B-Vax (B, MSD). (English)

1 reference

11 December 2017

2

Hilleman MR

1 reference

11 December 2017

McLean AA

1

1 reference

11 December 2017

McAleer WJ

series ordinal

3

1 reference

11 December 2017

Buynak EB

series ordinal

4

1 reference

11 December 2017

publication date

1 July 1983

1 reference

11 December 2017

1 reference

11 December 2017

volume

7 Suppl 1

1 reference

11 December 2017

page(s)

95-104

1 reference

The immune response of healthy adults to a reduced dose of hepatitis B vaccine

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

Immune responses to active and passive-active vaccination against hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

Immune response to hepatitis B vaccine in staff and patients in renal dialysis units

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

Immune response to hepatitis B vaccine in drug addicts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

Immune responses to hepatitis B vaccine in the mentally retarded

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

Immune response to hepatitis B vaccine in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

The cost-effectiveness of hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2883%2996879-2

7 January 2021

10.1016/S0163-4453(83)96879-2

Identifiers

DOI

1 reference

11 December 2017

1 reference